

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 7.56701181 |
| 2 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 7.56701181 |
| 3 | detection of temperature stimulus (GO:0016048) | 7.10353305 |
| 4 | positive regulation of cell size (GO:0045793) | 6.78554346 |
| 5 | positive regulation of meiotic cell cycle (GO:0051446) | 6.49451819 |
| 6 | syncytium formation (GO:0006949) | 6.39425809 |
| 7 | basic amino acid transport (GO:0015802) | 6.22160127 |
| 8 | L-alpha-amino acid transmembrane transport (GO:1902475) | 5.94378351 |
| 9 | regulation of cellular respiration (GO:0043457) | 5.89915228 |
| 10 | neuronal action potential (GO:0019228) | 5.88599745 |
| 11 | peripheral nervous system neuron development (GO:0048935) | 5.87625480 |
| 12 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 5.78466672 |
| 13 | negative regulation of meiotic cell cycle (GO:0051447) | 5.53867112 |
| 14 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 5.49174185 |
| 15 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 5.44042964 |
| 16 | mitotic G1 DNA damage checkpoint (GO:0031571) | 5.29376781 |
| 17 | neurofilament cytoskeleton organization (GO:0060052) | 5.22177951 |
| 18 | cell migration in hindbrain (GO:0021535) | 5.15856075 |
| 19 | mitotic G1/S transition checkpoint (GO:0044819) | 5.12313357 |
| 20 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 5.10942009 |
| 21 | potassium ion export (GO:0071435) | 5.07778927 |
| 22 | heme transport (GO:0015886) | 5.03979462 |
| 23 | proline transport (GO:0015824) | 5.00683888 |
| 24 | G1 DNA damage checkpoint (GO:0044783) | 4.88691469 |
| 25 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.82842072 |
| 26 | positive regulation of megakaryocyte differentiation (GO:0045654) | 4.82697182 |
| 27 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.62554384 |
| 28 | estrogen biosynthetic process (GO:0006703) | 4.56663638 |
| 29 | behavioral response to pain (GO:0048266) | 4.55566777 |
| 30 | membrane depolarization during action potential (GO:0086010) | 4.51185210 |
| 31 | negative regulation of macrophage differentiation (GO:0045650) | 4.50471974 |
| 32 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.45956614 |
| 33 | regulation of mitochondrial translation (GO:0070129) | 4.41461071 |
| 34 | ribosomal small subunit assembly (GO:0000028) | 4.38836071 |
| 35 | nucleoside transmembrane transport (GO:1901642) | 4.34099908 |
| 36 | neuronal action potential propagation (GO:0019227) | 4.28995923 |
| 37 | nucleoside transport (GO:0015858) | 4.24097897 |
| 38 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 4.23964294 |
| 39 | chaperone-mediated protein transport (GO:0072321) | 4.18310333 |
| 40 | response to water (GO:0009415) | 4.13372857 |
| 41 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.12704602 |
| 42 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 4.11246869 |
| 43 | placenta development (GO:0001890) | 4.10589959 |
| 44 | ribosomal small subunit biogenesis (GO:0042274) | 4.07064065 |
| 45 | negative regulation of JUN kinase activity (GO:0043508) | 4.06701956 |
| 46 | cellular response to ATP (GO:0071318) | 4.04397098 |
| 47 | adenosine metabolic process (GO:0046085) | 4.04006212 |
| 48 | DNA replication initiation (GO:0006270) | 4.00961900 |
| 49 | pseudouridine synthesis (GO:0001522) | 3.94765900 |
| 50 | retinal ganglion cell axon guidance (GO:0031290) | 3.93323759 |
| 51 | keratinocyte development (GO:0003334) | 3.92857403 |
| 52 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.91129111 |
| 53 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 3.90760523 |
| 54 | regulation of gene expression by genetic imprinting (GO:0006349) | 3.89143276 |
| 55 | response to pain (GO:0048265) | 3.87198497 |
| 56 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.83281534 |
| 57 | negative regulation of complement activation (GO:0045916) | 3.80224415 |
| 58 | viral transcription (GO:0019083) | 3.80159781 |
| 59 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.78267548 |
| 60 | positive regulation of muscle hypertrophy (GO:0014742) | 3.77205598 |
| 61 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.77205598 |
| 62 | glycine transport (GO:0015816) | 3.76472196 |
| 63 | translational termination (GO:0006415) | 3.74594083 |
| 64 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.74316045 |
| 65 | rRNA modification (GO:0000154) | 3.72985471 |
| 66 | embryonic placenta development (GO:0001892) | 3.72370418 |
| 67 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.71894344 |
| 68 | histamine secretion (GO:0001821) | 3.71346025 |
| 69 | positive regulation of hair follicle development (GO:0051798) | 3.70744352 |
| 70 | positive regulation of hair cycle (GO:0042635) | 3.70744352 |
| 71 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.69608163 |
| 72 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.69608163 |
| 73 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.68893671 |
| 74 | regulation of platelet aggregation (GO:0090330) | 3.65604245 |
| 75 | cell communication involved in cardiac conduction (GO:0086065) | 3.63972048 |
| 76 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.63754494 |
| 77 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.61387810 |
| 78 | ribosome biogenesis (GO:0042254) | 3.61107519 |
| 79 | formation of translation preinitiation complex (GO:0001731) | 3.58088562 |
| 80 | iron coordination entity transport (GO:1901678) | 3.57714393 |
| 81 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.56436886 |
| 82 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.54529835 |
| 83 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.54529835 |
| 84 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.53227775 |
| 85 | urogenital system development (GO:0001655) | 3.51772456 |
| 86 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.50816056 |
| 87 | polyamine biosynthetic process (GO:0006596) | 3.49550350 |
| 88 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.49196149 |
| 89 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.47707767 |
| 90 | synaptic vesicle maturation (GO:0016188) | 3.47457727 |
| 91 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 3.45009458 |
| 92 | UMP biosynthetic process (GO:0006222) | 3.45009458 |
| 93 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 3.45009458 |
| 94 | UMP metabolic process (GO:0046049) | 3.45009458 |
| 95 | urea cycle (GO:0000050) | 3.43546858 |
| 96 | tolerance induction (GO:0002507) | 3.43461414 |
| 97 | membrane repolarization (GO:0086009) | 3.42588866 |
| 98 | urinary tract smooth muscle contraction (GO:0014848) | 3.38998976 |
| 99 | sphingomyelin metabolic process (GO:0006684) | 3.38623037 |
| 100 | embryonic process involved in female pregnancy (GO:0060136) | 3.38016501 |
| 101 | translational initiation (GO:0006413) | 3.34985760 |
| 102 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.34603378 |
| 103 | termination of RNA polymerase III transcription (GO:0006386) | 3.34333473 |
| 104 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.34333473 |
| 105 | regulation of oxidative phosphorylation (GO:0002082) | 3.34100956 |
| 106 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.32218258 |
| 107 | hippo signaling (GO:0035329) | 3.30989830 |
| 108 | positive regulation of amino acid transport (GO:0051957) | 3.30764556 |
| 109 | establishment of epithelial cell polarity (GO:0090162) | 3.30577594 |
| 110 | action potential (GO:0001508) | 3.29288292 |
| 111 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 3.28592021 |
| 112 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.26566970 |
| 113 | alanine transport (GO:0032328) | 3.26406088 |
| 114 | enteric nervous system development (GO:0048484) | 3.25849122 |
| 115 | response to ATP (GO:0033198) | 3.25277863 |
| 116 | sprouting angiogenesis (GO:0002040) | 3.24767721 |
| 117 | N-terminal protein amino acid modification (GO:0031365) | 3.24514007 |
| 118 | translational elongation (GO:0006414) | 3.23689992 |
| 119 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 3.21642022 |
| 120 | cranial nerve development (GO:0021545) | 3.21268795 |
| 121 | viral life cycle (GO:0019058) | 3.21091596 |
| 122 | negative regulation of protein activation cascade (GO:2000258) | 3.19822605 |
| 123 | regulation of sensory perception of pain (GO:0051930) | 3.18170890 |
| 124 | regulation of sensory perception (GO:0051931) | 3.18170890 |
| 125 | protein localization to synapse (GO:0035418) | 3.17137501 |
| 126 | negative regulation of dendrite development (GO:2000171) | 3.16561740 |
| 127 | cofactor transport (GO:0051181) | 3.15577425 |
| 128 | nucleotide salvage (GO:0043173) | 3.15560067 |
| 129 | rRNA methylation (GO:0031167) | 3.14994912 |
| 130 | axon cargo transport (GO:0008088) | 3.14530827 |
| 131 | digestive tract morphogenesis (GO:0048546) | 3.13003767 |
| 132 | female genitalia development (GO:0030540) | 3.12442105 |
| 133 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.10963745 |
| 134 | translation (GO:0006412) | 3.10890168 |
| 135 | glutamate secretion (GO:0014047) | 3.09905652 |
| 136 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 3.09758117 |
| 137 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.08001222 |
| 138 | maturation of SSU-rRNA (GO:0030490) | 3.06379231 |
| 139 | urea metabolic process (GO:0019627) | 3.06299077 |
| 140 | regulation of histone phosphorylation (GO:0033127) | 3.05444998 |
| 141 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.05335096 |
| 142 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.04865747 |
| 143 | negative regulation of macroautophagy (GO:0016242) | 3.03598107 |
| 144 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.03237546 |
| 145 | sodium ion transmembrane transport (GO:0035725) | 3.01562981 |
| 146 | regulation of odontogenesis (GO:0042481) | 3.00902958 |
| 147 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.99647858 |
| 148 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.99636052 |
| 149 | genetic imprinting (GO:0071514) | 2.99048246 |
| 150 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.98790124 |
| 151 | layer formation in cerebral cortex (GO:0021819) | 2.98182572 |
| 152 | negative regulation of Notch signaling pathway (GO:0045746) | 2.95566985 |
| 153 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.94514128 |
| 154 | protein targeting to mitochondrion (GO:0006626) | 2.94051922 |
| 155 | ribosomal large subunit biogenesis (GO:0042273) | 2.93563669 |
| 156 | ncRNA 3-end processing (GO:0043628) | 2.92412088 |
| 157 | cotranslational protein targeting to membrane (GO:0006613) | 2.92331549 |
| 158 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.91104470 |
| 159 | protein targeting to ER (GO:0045047) | 2.90668593 |
| 160 | sensory perception of pain (GO:0019233) | 2.89740051 |
| 161 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.89697483 |
| 162 | cellular protein complex disassembly (GO:0043624) | 2.87993088 |
| 163 | innervation (GO:0060384) | 2.87566935 |
| 164 | regulation of early endosome to late endosome transport (GO:2000641) | 2.85684788 |
| 165 | dopamine receptor signaling pathway (GO:0007212) | 2.85547900 |
| 166 | plasma membrane repair (GO:0001778) | 2.84777383 |
| 167 | response to xenobiotic stimulus (GO:0009410) | 2.84309536 |
| 168 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.80987443 |
| 169 | microtubule polymerization or depolymerization (GO:0031109) | 2.79513662 |
| 170 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.79296475 |
| 171 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.78902685 |
| 172 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.75939927 |
| 173 | positive regulation of potassium ion transport (GO:0043268) | 2.74750934 |
| 174 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.73936076 |
| 175 | neuron fate specification (GO:0048665) | 2.73080669 |
| 176 | organelle transport along microtubule (GO:0072384) | 2.72413566 |
| 177 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.69817238 |
| 178 | glycosphingolipid biosynthetic process (GO:0006688) | 2.69795124 |
| 179 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.68960436 |
| 180 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.67555437 |
| 181 | regulation of collateral sprouting (GO:0048670) | 2.67270891 |
| 182 | negative regulation of humoral immune response (GO:0002921) | 2.66841595 |
| 183 | negative regulation of microtubule polymerization (GO:0031115) | 2.66004204 |
| 184 | regulation of membrane repolarization (GO:0060306) | 2.62919477 |
| 185 | membrane depolarization (GO:0051899) | 2.62003437 |
| 186 | nerve growth factor signaling pathway (GO:0038180) | 2.61425598 |
| 187 | regulation of dopamine secretion (GO:0014059) | 2.60213732 |
| 188 | establishment of mitochondrion localization (GO:0051654) | 2.59959038 |
| 189 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.59059913 |
| 190 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.56860964 |
| 191 | negative regulation of cation channel activity (GO:2001258) | 2.56784435 |
| 192 | vesicle transport along microtubule (GO:0047496) | 2.56171604 |
| 193 | membrane repolarization during action potential (GO:0086011) | 2.53815714 |
| 194 | synaptic vesicle exocytosis (GO:0016079) | 2.51876353 |
| 195 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.51407557 |
| 196 | protein polyglutamylation (GO:0018095) | 2.49369194 |
| 197 | negative regulation of heart rate (GO:0010459) | 2.48490915 |
| 198 | neuron cell-cell adhesion (GO:0007158) | 2.47034865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.60398840 |
| 2 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.50571319 |
| 3 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 3.48691190 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.34925483 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.23462313 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.21398566 |
| 7 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.08902861 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.05819864 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.97700634 |
| 10 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.92052309 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.87172298 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.79238271 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.70926544 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.65914930 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.65491101 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.63714757 |
| 17 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.58855885 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50396597 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37009163 |
| 20 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.32546918 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.32428454 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.30664210 |
| 23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.29053987 |
| 24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.25236651 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.25016729 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.20966970 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.19416276 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.18981611 |
| 29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.15505399 |
| 30 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.11884075 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.11884075 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.11219205 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05304603 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.98643985 |
| 35 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.97311413 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.96439693 |
| 37 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.95623403 |
| 38 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.94880701 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.92419839 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.92404499 |
| 41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.89275485 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.88240195 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.84979860 |
| 44 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.84265747 |
| 45 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.79369244 |
| 46 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.79005313 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.78897408 |
| 48 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.78327077 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.78032930 |
| 50 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.73860695 |
| 51 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.73003218 |
| 52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.72976188 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.72010282 |
| 54 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.68834980 |
| 55 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66738003 |
| 56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.66622020 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.65433531 |
| 58 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.63961703 |
| 59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.61099640 |
| 60 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.59814883 |
| 61 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.59737841 |
| 62 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57607088 |
| 63 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.57366616 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.57315164 |
| 65 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.53599448 |
| 66 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.51637739 |
| 67 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.50353579 |
| 68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47928483 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47618104 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47323713 |
| 71 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.46208125 |
| 72 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.44673075 |
| 73 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.44228928 |
| 74 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.41959071 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41383191 |
| 76 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.41234400 |
| 77 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38382556 |
| 78 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38349954 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.37267575 |
| 80 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.37248449 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.35883194 |
| 82 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34772271 |
| 83 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32987090 |
| 84 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31611901 |
| 85 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.30446919 |
| 86 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29727031 |
| 87 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.29688375 |
| 88 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.29303870 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28665449 |
| 90 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27284035 |
| 91 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.27074283 |
| 92 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26884274 |
| 93 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.26457506 |
| 94 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.26160002 |
| 95 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.25789584 |
| 96 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.25789584 |
| 97 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.25789584 |
| 98 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25237516 |
| 99 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25204414 |
| 100 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24842631 |
| 101 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24368444 |
| 102 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23006902 |
| 103 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.21680350 |
| 104 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.21290495 |
| 105 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21067811 |
| 106 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21025564 |
| 107 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.20562974 |
| 108 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.20263425 |
| 109 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.20054030 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20025559 |
| 111 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19738878 |
| 112 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18818547 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18042883 |
| 114 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17608550 |
| 115 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.17042442 |
| 116 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16447404 |
| 117 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.15802928 |
| 118 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.14847953 |
| 119 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14839656 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14596915 |
| 121 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13858789 |
| 122 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.13640328 |
| 123 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13382587 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12978280 |
| 125 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12460107 |
| 126 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11699335 |
| 127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11577216 |
| 128 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.10637982 |
| 129 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09679839 |
| 130 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.09570318 |
| 131 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07832802 |
| 132 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06639389 |
| 133 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05693090 |
| 134 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.05218309 |
| 135 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.03827772 |
| 136 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03404974 |
| 137 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.03346725 |
| 138 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.03065886 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02355199 |
| 140 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02206927 |
| 141 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.01910551 |
| 142 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01808619 |
| 143 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.01384963 |
| 144 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99035150 |
| 145 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.97624313 |
| 146 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.97601132 |
| 147 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97513048 |
| 148 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.97140262 |
| 149 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.97127957 |
| 150 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96461942 |
| 151 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96235318 |
| 152 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95828235 |
| 153 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95548523 |
| 154 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.95383501 |
| 155 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94721789 |
| 156 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94626457 |
| 157 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.94584292 |
| 158 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.94409690 |
| 159 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94322940 |
| 160 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94314549 |
| 161 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94314549 |
| 162 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93959722 |
| 163 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.92913578 |
| 164 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92254148 |
| 165 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92082012 |
| 166 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91856552 |
| 167 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91628465 |
| 168 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90911794 |
| 169 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90762513 |
| 170 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.90705050 |
| 171 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.90640553 |
| 172 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90570749 |
| 173 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.90426164 |
| 174 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87808870 |
| 175 | STAT3_23295773_ChIP-Seq_U87_Human | 0.87710682 |
| 176 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86718908 |
| 177 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86718908 |
| 178 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86174542 |
| 179 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86118323 |
| 180 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86001312 |
| 181 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.85779556 |
| 182 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.85145390 |
| 183 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85053232 |
| 184 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84312524 |
| 185 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.83881801 |
| 186 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83844702 |
| 187 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.83803105 |
| 188 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.82761092 |
| 189 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81386753 |
| 190 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.81278700 |
| 191 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.81042563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001968_abnormal_touch/_nociception | 7.45445330 |
| 2 | MP0002735_abnormal_chemical_nociception | 7.01466467 |
| 3 | MP0002736_abnormal_nociception_after | 6.61327423 |
| 4 | MP0001986_abnormal_taste_sensitivity | 5.16950282 |
| 5 | MP0004270_analgesia | 4.67820114 |
| 6 | MP0002796_impaired_skin_barrier | 4.36770166 |
| 7 | MP0006276_abnormal_autonomic_nervous | 4.21278297 |
| 8 | MP0002733_abnormal_thermal_nociception | 4.17195036 |
| 9 | MP0004858_abnormal_nervous_system | 3.92815680 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 3.85713477 |
| 11 | MP0001970_abnormal_pain_threshold | 3.61646029 |
| 12 | MP0008995_early_reproductive_senescence | 3.29456177 |
| 13 | MP0000647_abnormal_sebaceous_gland | 3.21165910 |
| 14 | MP0002098_abnormal_vibrissa_morphology | 2.71936878 |
| 15 | MP0004185_abnormal_adipocyte_glucose | 2.66484510 |
| 16 | MP0005501_abnormal_skin_physiology | 2.57432174 |
| 17 | MP0004782_abnormal_surfactant_physiolog | 2.50778414 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 2.45078208 |
| 19 | MP0002272_abnormal_nervous_system | 2.39745452 |
| 20 | MP0004147_increased_porphyrin_level | 2.34314405 |
| 21 | MP0003880_abnormal_central_pattern | 2.05799832 |
| 22 | MP0010307_abnormal_tumor_latency | 2.04223056 |
| 23 | MP0008004_abnormal_stomach_pH | 11.2145758 |
| 24 | MP0000003_abnormal_adipose_tissue | 1.98537395 |
| 25 | MP0000516_abnormal_urinary_system | 1.94831199 |
| 26 | MP0005367_renal/urinary_system_phenotyp | 1.94831199 |
| 27 | MP0002751_abnormal_autonomic_nervous | 1.90546018 |
| 28 | MP0002067_abnormal_sensory_capabilities | 1.89271785 |
| 29 | MP0009379_abnormal_foot_pigmentation | 1.86455798 |
| 30 | MP0009672_abnormal_birth_weight | 1.84454526 |
| 31 | MP0003303_peritoneal_inflammation | 1.72012667 |
| 32 | MP0002184_abnormal_innervation | 1.71576693 |
| 33 | MP0003635_abnormal_synaptic_transmissio | 1.65157967 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.62861886 |
| 35 | MP0000372_irregular_coat_pigmentation | 1.61408827 |
| 36 | MP0005670_abnormal_white_adipose | 1.59193540 |
| 37 | MP0005375_adipose_tissue_phenotype | 1.58699064 |
| 38 | MP0001348_abnormal_lacrimal_gland | 1.58692485 |
| 39 | MP0008877_abnormal_DNA_methylation | 1.51226193 |
| 40 | MP0000920_abnormal_myelination | 1.49190440 |
| 41 | MP0008260_abnormal_autophagy | 1.47900625 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.47634223 |
| 43 | MP0002064_seizures | 1.41150067 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 1.40533348 |
| 45 | MP0001764_abnormal_homeostasis | 1.36078352 |
| 46 | MP0000377_abnormal_hair_follicle | 1.34823809 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.34764354 |
| 48 | MP0000955_abnormal_spinal_cord | 1.34656263 |
| 49 | MP0003693_abnormal_embryo_hatching | 1.34311582 |
| 50 | MP0002127_abnormal_cardiovascular_syste | 1.33225936 |
| 51 | MP0005666_abnormal_adipose_tissue | 1.29422302 |
| 52 | MP0005083_abnormal_biliary_tract | 1.28428707 |
| 53 | MP0009745_abnormal_behavioral_response | 1.26172234 |
| 54 | MP0009046_muscle_twitch | 1.25103072 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.24888553 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.24888553 |
| 57 | MP0003786_premature_aging | 1.24651959 |
| 58 | MP0003329_amyloid_beta_deposits | 1.23848171 |
| 59 | MP0009115_abnormal_fat_cell | 1.20547760 |
| 60 | MP0003634_abnormal_glial_cell | 1.20398541 |
| 61 | MP0003186_abnormal_redox_activity | 1.19598664 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.19065633 |
| 63 | MP0005423_abnormal_somatic_nervous | 1.18416929 |
| 64 | MP0001485_abnormal_pinna_reflex | 1.17537373 |
| 65 | MP0002063_abnormal_learning/memory/cond | 1.16040334 |
| 66 | MP0001216_abnormal_epidermal_layer | 1.14848424 |
| 67 | MP0000383_abnormal_hair_follicle | 1.11958594 |
| 68 | MP0009697_abnormal_copulation | 1.10867204 |
| 69 | MP0002572_abnormal_emotion/affect_behav | 1.09919533 |
| 70 | MP0008874_decreased_physiological_sensi | 1.09751224 |
| 71 | MP0001270_distended_abdomen | 1.09670596 |
| 72 | MP0001486_abnormal_startle_reflex | 1.08734445 |
| 73 | MP0003633_abnormal_nervous_system | 1.08719055 |
| 74 | MP0001984_abnormal_olfaction | 1.08143898 |
| 75 | MP0004957_abnormal_blastocyst_morpholog | 1.07292788 |
| 76 | MP0001730_embryonic_growth_arrest | 1.06258850 |
| 77 | MP0002882_abnormal_neuron_morphology | 1.02605355 |
| 78 | MP0004233_abnormal_muscle_weight | 1.01452702 |
| 79 | MP0010094_abnormal_chromosome_stability | 1.00861993 |
| 80 | MP0000778_abnormal_nervous_system | 1.00087555 |
| 81 | MP0009703_decreased_birth_body | 0.99870143 |
| 82 | MP0000749_muscle_degeneration | 0.99862577 |
| 83 | MP0002229_neurodegeneration | 0.99029055 |
| 84 | MP0005023_abnormal_wound_healing | 0.98855141 |
| 85 | MP0001346_abnormal_lacrimal_gland | 0.95998082 |
| 86 | MP0003631_nervous_system_phenotype | 0.95329451 |
| 87 | MP0000747_muscle_weakness | 0.94629603 |
| 88 | MP0002160_abnormal_reproductive_system | 0.92715605 |
| 89 | MP0000367_abnormal_coat/_hair | 0.92568103 |
| 90 | MP0005171_absent_coat_pigmentation | 0.90174810 |
| 91 | MP0002066_abnormal_motor_capabilities/c | 0.89682685 |
| 92 | MP0010771_integument_phenotype | 0.88081377 |
| 93 | MP0000230_abnormal_systemic_arterial | 0.87104452 |
| 94 | MP0002086_abnormal_extraembryonic_tissu | 0.87101145 |
| 95 | MP0004264_abnormal_extraembryonic_tissu | 0.86840551 |
| 96 | MP0008789_abnormal_olfactory_epithelium | 0.86687906 |
| 97 | MP0002837_dystrophic_cardiac_calcinosis | 0.85765751 |
| 98 | MP0008775_abnormal_heart_ventricle | 0.85442240 |
| 99 | MP0009840_abnormal_foam_cell | 0.85426950 |
| 100 | MP0010678_abnormal_skin_adnexa | 0.84243266 |
| 101 | MP0001727_abnormal_embryo_implantation | 0.82146516 |
| 102 | MP0001663_abnormal_digestive_system | 0.81630685 |
| 103 | MP0000604_amyloidosis | 0.79531953 |
| 104 | MP0001243_abnormal_dermal_layer | 0.77413167 |
| 105 | MP0003045_fibrosis | 0.76962583 |
| 106 | MP0003448_altered_tumor_morphology | 0.76006603 |
| 107 | MP0003936_abnormal_reproductive_system | 0.75204376 |
| 108 | MP0000358_abnormal_cell_content/ | 0.74930595 |
| 109 | MP0000013_abnormal_adipose_tissue | 0.74152164 |
| 110 | MP0005535_abnormal_body_temperature | 0.73911921 |
| 111 | MP0003632_abnormal_nervous_system | 0.73272151 |
| 112 | MP0004742_abnormal_vestibular_system | 0.73146746 |
| 113 | MP0002638_abnormal_pupillary_reflex | 0.71026616 |
| 114 | MP0003718_maternal_effect | 0.70801503 |
| 115 | MP0003942_abnormal_urinary_system | 0.69306097 |
| 116 | MP0004142_abnormal_muscle_tone | 0.68717251 |
| 117 | MP0002752_abnormal_somatic_nervous | 0.68065594 |
| 118 | MP0003878_abnormal_ear_physiology | 0.68013471 |
| 119 | MP0005377_hearing/vestibular/ear_phenot | 0.68013471 |
| 120 | MP0002210_abnormal_sex_determination | 0.67974972 |
| 121 | MP0002396_abnormal_hematopoietic_system | 0.67631433 |
| 122 | MP0005165_increased_susceptibility_to | 0.67487882 |
| 123 | MP0000470_abnormal_stomach_morphology | 0.67038635 |
| 124 | MP0001697_abnormal_embryo_size | 0.65186313 |
| 125 | MP0000427_abnormal_hair_cycle | 0.64580618 |
| 126 | MP0002909_abnormal_adrenal_gland | 0.63718863 |
| 127 | MP0001672_abnormal_embryogenesis/_devel | 0.63653163 |
| 128 | MP0005380_embryogenesis_phenotype | 0.63653163 |
| 129 | MP0005381_digestive/alimentary_phenotyp | 0.62822918 |
| 130 | MP0002876_abnormal_thyroid_physiology | 0.62622096 |
| 131 | MP0002557_abnormal_social/conspecific_i | 0.62320442 |
| 132 | MP0005389_reproductive_system_phenotype | 0.62206498 |
| 133 | MP0001881_abnormal_mammary_gland | 0.62170529 |
| 134 | MP0001440_abnormal_grooming_behavior | 0.61580837 |
| 135 | MP0005623_abnormal_meninges_morphology | 0.60850714 |
| 136 | MP0005499_abnormal_olfactory_system | 0.60449700 |
| 137 | MP0005394_taste/olfaction_phenotype | 0.60449700 |
| 138 | MP0008569_lethality_at_weaning | 0.59886410 |
| 139 | MP0001905_abnormal_dopamine_level | 0.59612808 |
| 140 | MP0005085_abnormal_gallbladder_physiolo | 0.59462463 |
| 141 | MP0000751_myopathy | 0.59461415 |
| 142 | MP0000534_abnormal_ureter_morphology | 0.59048605 |
| 143 | MP0004085_abnormal_heartbeat | 0.58965592 |
| 144 | MP0000579_abnormal_nail_morphology | 0.58759231 |
| 145 | MP0004924_abnormal_behavior | 0.58497857 |
| 146 | MP0005386_behavior/neurological_phenoty | 0.58497857 |
| 147 | MP0002080_prenatal_lethality | 0.58360515 |
| 148 | MP0008770_decreased_survivor_rate | 0.57539696 |
| 149 | MP0002970_abnormal_white_adipose | 0.57539180 |
| 150 | MP0000538_abnormal_urinary_bladder | 0.56049994 |
| 151 | MP0001661_extended_life_span | 0.55733229 |
| 152 | MP0008932_abnormal_embryonic_tissue | 0.53956295 |
| 153 | MP0001756_abnormal_urination | 0.53943839 |
| 154 | MP0001145_abnormal_male_reproductive | 0.53454280 |
| 155 | MP0002088_abnormal_embryonic_growth/wei | 0.53217082 |
| 156 | MP0003984_embryonic_growth_retardation | 0.52776887 |
| 157 | MP0006035_abnormal_mitochondrial_morpho | 0.52426898 |
| 158 | MP0005448_abnormal_energy_balance | 0.52348763 |
| 159 | MP0009931_abnormal_skin_appearance | 0.52243219 |
| 160 | MP0003136_yellow_coat_color | 0.51563455 |
| 161 | MP0004484_altered_response_of | 0.51264190 |
| 162 | MP0010234_abnormal_vibrissa_follicle | 0.50601804 |
| 163 | MP0003690_abnormal_glial_cell | 0.50313152 |
| 164 | MP0004036_abnormal_muscle_relaxation | 0.48276438 |
| 165 | MP0005451_abnormal_body_composition | 0.48165473 |
| 166 | MP0001299_abnormal_eye_distance/ | 0.47428548 |
| 167 | MP0003283_abnormal_digestive_organ | 0.45867795 |
| 168 | MP0001188_hyperpigmentation | 0.44799138 |
| 169 | MP0001765_abnormal_ion_homeostasis | 0.44121832 |
| 170 | MP0004145_abnormal_muscle_electrophysio | 0.43707280 |
| 171 | MP0004510_myositis | 0.41232456 |
| 172 | MP0008872_abnormal_physiological_respon | 0.40621874 |
| 173 | MP0001963_abnormal_hearing_physiology | 0.40188433 |
| 174 | MP0001664_abnormal_digestion | 0.40062905 |
| 175 | MP0003806_abnormal_nucleotide_metabolis | 0.39083784 |
| 176 | MP0004883_abnormal_blood_vessel | 0.38771396 |
| 177 | MP0002972_abnormal_cardiac_muscle | 0.37027011 |
| 178 | MP0001501_abnormal_sleep_pattern | 0.36974388 |
| 179 | MP0004215_abnormal_myocardial_fiber | 0.33599893 |
| 180 | MP0000639_abnormal_adrenal_gland | 0.33082293 |
| 181 | MP0005464_abnormal_platelet_physiology | 0.32914924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ulnar claw (HP:0001178) | 9.14856853 |
| 2 | Amelogenesis imperfecta (HP:0000705) | 7.49289348 |
| 3 | Segmental peripheral demyelination/remyelination (HP:0003481) | 7.18322357 |
| 4 | Insidious onset (HP:0003587) | 6.73533124 |
| 5 | Termporal pattern (HP:0011008) | 6.73533124 |
| 6 | Aplastic anemia (HP:0001915) | 6.32193663 |
| 7 | Action tremor (HP:0002345) | 6.28869295 |
| 8 | Abnormality of dental color (HP:0011073) | 5.96236664 |
| 9 | Myokymia (HP:0002411) | 5.88868586 |
| 10 | Fragile nails (HP:0001808) | 5.72725282 |
| 11 | Woolly hair (HP:0002224) | 5.50675478 |
| 12 | Dysautonomia (HP:0002459) | 5.49374213 |
| 13 | Abnormality of the frontal sinuses (HP:0002687) | 5.28478371 |
| 14 | Onion bulb formation (HP:0003383) | 4.80711169 |
| 15 | Male infertility (HP:0003251) | 4.80126952 |
| 16 | Impaired pain sensation (HP:0007328) | 4.78150314 |
| 17 | Abnormality of pain sensation (HP:0010832) | 4.78150314 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 4.72047952 |
| 19 | Microvesicular hepatic steatosis (HP:0001414) | 4.70205815 |
| 20 | Foot dorsiflexor weakness (HP:0009027) | 4.66481687 |
| 21 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 4.55135803 |
| 22 | Steppage gait (HP:0003376) | 4.38677153 |
| 23 | Cerebral hypomyelination (HP:0006808) | 4.37550095 |
| 24 | Peripheral hypomyelination (HP:0007182) | 4.34967229 |
| 25 | Hammertoe (HP:0001765) | 4.32903158 |
| 26 | Abnormality of the foot musculature (HP:0001436) | 4.20358066 |
| 27 | Pheochromocytoma (HP:0002666) | 4.01194596 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.95876754 |
| 29 | Paralysis (HP:0003470) | 3.88958591 |
| 30 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.85143699 |
| 31 | Seborrheic dermatitis (HP:0001051) | 3.83772135 |
| 32 | Abnormal number of erythroid precursors (HP:0012131) | 3.81223049 |
| 33 | Abnormal autonomic nervous system physiology (HP:0012332) | 3.71481118 |
| 34 | Right ventricular cardiomyopathy (HP:0011663) | 3.70317771 |
| 35 | Axonal loss (HP:0003447) | 3.55166893 |
| 36 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.52830718 |
| 37 | Impaired proprioception (HP:0010831) | 3.52048341 |
| 38 | Retinal atrophy (HP:0001105) | 3.52005773 |
| 39 | Abnormality of the dental root (HP:0006486) | 3.49508885 |
| 40 | Taurodontia (HP:0000679) | 3.49508885 |
| 41 | Abnormality of permanent molar morphology (HP:0011071) | 3.49508885 |
| 42 | Sensory axonal neuropathy (HP:0003390) | 3.46363588 |
| 43 | Neuroendocrine neoplasm (HP:0100634) | 3.43862282 |
| 44 | Hypergonadotropic hypogonadism (HP:0000815) | 3.42985791 |
| 45 | Focal seizures (HP:0007359) | 3.41600616 |
| 46 | Distal sensory impairment (HP:0002936) | 3.34368672 |
| 47 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.32937362 |
| 48 | Decreased motor nerve conduction velocity (HP:0003431) | 3.30626281 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.27828432 |
| 50 | Increased CSF protein (HP:0002922) | 3.27233345 |
| 51 | Peripheral demyelination (HP:0011096) | 3.25999412 |
| 52 | Distal arthrogryposis (HP:0005684) | 3.23635182 |
| 53 | Hyporeflexia of lower limbs (HP:0002600) | 3.22818017 |
| 54 | Abnormality of molar (HP:0011077) | 3.22646213 |
| 55 | Abnormality of molar morphology (HP:0011070) | 3.22646213 |
| 56 | Myotonia (HP:0002486) | 3.22355686 |
| 57 | Cerebellar dysplasia (HP:0007033) | 3.20357987 |
| 58 | Abnormality of the dental pulp (HP:0006479) | 3.11588020 |
| 59 | Abnormality of transition element cation homeostasis (HP:0011030) | 3.07238047 |
| 60 | Abnormality of the corticospinal tract (HP:0002492) | 3.05107616 |
| 61 | Focal motor seizures (HP:0011153) | 2.97702286 |
| 62 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.94769266 |
| 63 | Abnormality of the vocal cords (HP:0008777) | 2.92774078 |
| 64 | Birth length less than 3rd percentile (HP:0003561) | 2.92216775 |
| 65 | Breast hypoplasia (HP:0003187) | 2.91285405 |
| 66 | Visual hallucinations (HP:0002367) | 2.90640138 |
| 67 | Postural tremor (HP:0002174) | 2.89749146 |
| 68 | Abnormality of iron homeostasis (HP:0011031) | 2.89026901 |
| 69 | Increased circulating renin level (HP:0000848) | 2.84668532 |
| 70 | Upper limb muscle weakness (HP:0003484) | 2.84479642 |
| 71 | Autoamputation (HP:0001218) | 2.82173431 |
| 72 | Ventricular fibrillation (HP:0001663) | 2.70206919 |
| 73 | Premature ovarian failure (HP:0008209) | 2.67777523 |
| 74 | Carpal bone hypoplasia (HP:0001498) | 2.67180864 |
| 75 | Hepatocellular necrosis (HP:0001404) | 2.66197616 |
| 76 | Increased serum ferritin (HP:0003281) | 2.66143674 |
| 77 | Renal tubular acidosis (HP:0001947) | 2.66091808 |
| 78 | CNS hypomyelination (HP:0003429) | 2.65158856 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 2.64956530 |
| 80 | Aplasia of the musculature (HP:0100854) | 2.64893985 |
| 81 | Urinary urgency (HP:0000012) | 2.64704809 |
| 82 | Vacuolated lymphocytes (HP:0001922) | 2.64479851 |
| 83 | Progressive muscle weakness (HP:0003323) | 2.58721519 |
| 84 | Rapidly progressive (HP:0003678) | 2.57718356 |
| 85 | Ankle clonus (HP:0011448) | 2.57351314 |
| 86 | Pallor (HP:0000980) | 2.56876883 |
| 87 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.55890251 |
| 88 | Increased serum lactate (HP:0002151) | 2.53712707 |
| 89 | Neurofibrillary tangles (HP:0002185) | 2.53314757 |
| 90 | Malnutrition (HP:0004395) | 2.52440813 |
| 91 | Hypothermia (HP:0002045) | 2.50797960 |
| 92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.46672111 |
| 93 | Septate vagina (HP:0001153) | 2.46445289 |
| 94 | Abnormal pancreas size (HP:0012094) | 2.45254530 |
| 95 | Tetany (HP:0001281) | 2.42657646 |
| 96 | Nausea (HP:0002018) | 2.39192042 |
| 97 | Increased CSF lactate (HP:0002490) | 2.38544921 |
| 98 | Widely spaced teeth (HP:0000687) | 2.38499866 |
| 99 | Reticulocytopenia (HP:0001896) | 2.38074566 |
| 100 | Dialeptic seizures (HP:0011146) | 2.36464791 |
| 101 | Bradycardia (HP:0001662) | 2.35908621 |
| 102 | Abnormality of magnesium homeostasis (HP:0004921) | 2.34531563 |
| 103 | Hypomagnesemia (HP:0002917) | 2.33988887 |
| 104 | Severe visual impairment (HP:0001141) | 2.33545863 |
| 105 | Hypoventilation (HP:0002791) | 2.32099880 |
| 106 | Atonic seizures (HP:0010819) | 2.31299363 |
| 107 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.30416697 |
| 108 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.30416697 |
| 109 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.29218079 |
| 110 | Renal tubular dysfunction (HP:0000124) | 2.28056364 |
| 111 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.25484928 |
| 112 | Lactic acidosis (HP:0003128) | 2.19392031 |
| 113 | Hepatic necrosis (HP:0002605) | 2.18584071 |
| 114 | Hyperglycinuria (HP:0003108) | 2.17986759 |
| 115 | Progressive inability to walk (HP:0002505) | 2.16598616 |
| 116 | CNS demyelination (HP:0007305) | 2.14041856 |
| 117 | Thyroid carcinoma (HP:0002890) | 2.11120542 |
| 118 | Progressive cerebellar ataxia (HP:0002073) | 2.08826928 |
| 119 | Failure to thrive in infancy (HP:0001531) | 2.08803821 |
| 120 | Ureteral duplication (HP:0000073) | 2.07540755 |
| 121 | Split foot (HP:0001839) | 2.06628049 |
| 122 | Lower limb muscle weakness (HP:0007340) | 2.05100439 |
| 123 | Arthropathy (HP:0003040) | 2.02835776 |
| 124 | Generalized tonic-clonic seizures (HP:0002069) | 2.02111526 |
| 125 | Abnormality of the aortic arch (HP:0012303) | 2.00785954 |
| 126 | Spastic gait (HP:0002064) | 2.00590478 |
| 127 | Hyperglycemia (HP:0003074) | 2.00503977 |
| 128 | Thoracolumbar scoliosis (HP:0002944) | 1.99903862 |
| 129 | Insomnia (HP:0100785) | 1.98821321 |
| 130 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.98317167 |
| 131 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.97421355 |
| 132 | Craniofacial hyperostosis (HP:0004493) | 1.96427722 |
| 133 | Hypercortisolism (HP:0001578) | 1.96231396 |
| 134 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.96094161 |
| 135 | Bile duct proliferation (HP:0001408) | 1.95692963 |
| 136 | Abnormal biliary tract physiology (HP:0012439) | 1.95692963 |
| 137 | Cerebral hemorrhage (HP:0001342) | 1.95213815 |
| 138 | Truncal ataxia (HP:0002078) | 1.93243689 |
| 139 | Mitochondrial inheritance (HP:0001427) | 1.92629347 |
| 140 | Distal lower limb muscle weakness (HP:0009053) | 1.91571207 |
| 141 | Cone-rod dystrophy (HP:0000548) | 1.88742312 |
| 142 | Cerebral inclusion bodies (HP:0100314) | 1.88730630 |
| 143 | Osteomalacia (HP:0002749) | 1.88598280 |
| 144 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.88419249 |
| 145 | Rough bone trabeculation (HP:0100670) | 1.88071951 |
| 146 | EMG: neuropathic changes (HP:0003445) | 1.87695342 |
| 147 | Prolonged QT interval (HP:0001657) | 1.87435757 |
| 148 | Postural instability (HP:0002172) | 1.86228074 |
| 149 | Proximal tubulopathy (HP:0000114) | 1.85140989 |
| 150 | Absent forearm bone (HP:0003953) | 1.84369810 |
| 151 | Aplasia involving forearm bones (HP:0009822) | 1.84369810 |
| 152 | Increased hepatocellular lipid droplets (HP:0006565) | 1.83762787 |
| 153 | Muscle fibrillation (HP:0010546) | 1.83595994 |
| 154 | Absence seizures (HP:0002121) | 1.83085462 |
| 155 | Muscle fiber splitting (HP:0003555) | 1.81790228 |
| 156 | Secondary amenorrhea (HP:0000869) | 1.80790349 |
| 157 | Glycosuria (HP:0003076) | 1.80663324 |
| 158 | Abnormality of urine glucose concentration (HP:0011016) | 1.80663324 |
| 159 | Facial shape deformation (HP:0011334) | 1.79355271 |
| 160 | Potter facies (HP:0002009) | 1.79355271 |
| 161 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.79337875 |
| 162 | Neuronal loss in central nervous system (HP:0002529) | 1.78327082 |
| 163 | Hypoplasia of the uterus (HP:0000013) | 1.78254670 |
| 164 | Multiple enchondromatosis (HP:0005701) | 1.78080113 |
| 165 | Azoospermia (HP:0000027) | 1.77494082 |
| 166 | Episodic fever (HP:0001954) | 1.75540335 |
| 167 | Cholecystitis (HP:0001082) | 1.74972959 |
| 168 | Abnormal gallbladder physiology (HP:0012438) | 1.74972959 |
| 169 | Pancytopenia (HP:0001876) | 1.74617847 |
| 170 | Absent radius (HP:0003974) | 1.73964225 |
| 171 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.73200094 |
| 172 | Single umbilical artery (HP:0001195) | 1.73200094 |
| 173 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.73200094 |
| 174 | Death in infancy (HP:0001522) | 1.72660049 |
| 175 | Neonatal onset (HP:0003623) | 1.72156823 |
| 176 | Febrile seizures (HP:0002373) | 1.71295947 |
| 177 | Pes cavus (HP:0001761) | 1.71023742 |
| 178 | Partial agenesis of the corpus callosum (HP:0001338) | 1.70944582 |
| 179 | Slow progression (HP:0003677) | 1.70804598 |
| 180 | Orthostatic hypotension (HP:0001278) | 1.70543886 |
| 181 | Double outlet right ventricle (HP:0001719) | 1.70229340 |
| 182 | Congenital malformation of the right heart (HP:0011723) | 1.70229340 |
| 183 | Bicornuate uterus (HP:0000813) | 1.69317565 |
| 184 | Lower limb asymmetry (HP:0100559) | 1.66862352 |
| 185 | Muscle stiffness (HP:0003552) | 1.64447471 |
| 186 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.64369532 |
| 187 | Abnormal eating behavior (HP:0100738) | 1.63473427 |
| 188 | Areflexia of lower limbs (HP:0002522) | 1.63370568 |
| 189 | Amblyopia (HP:0000646) | 1.60156083 |
| 190 | Broad alveolar ridges (HP:0000187) | 1.60079385 |
| 191 | Stridor (HP:0010307) | 1.58980393 |
| 192 | Paraplegia (HP:0010550) | 1.58895873 |
| 193 | Anosmia (HP:0000458) | 1.57983304 |
| 194 | Bowel diverticulosis (HP:0005222) | 1.57543194 |
| 195 | Spastic paraplegia (HP:0001258) | 1.55739050 |
| 196 | Hypoplasia of the brainstem (HP:0002365) | 1.54934231 |
| 197 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.54934231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.34702468 |
| 2 | KSR2 | 5.14140790 |
| 3 | EPHA2 | 4.65267475 |
| 4 | MAP3K2 | 4.34563905 |
| 5 | NTRK1 | 3.91834856 |
| 6 | PDK2 | 3.82917244 |
| 7 | TYRO3 | 3.62977972 |
| 8 | RIPK4 | 3.54124754 |
| 9 | NTRK3 | 3.47624812 |
| 10 | LIMK1 | 3.42440718 |
| 11 | NME1 | 3.09497217 |
| 12 | SIK3 | 3.05739436 |
| 13 | AKT3 | 3.05709637 |
| 14 | OXSR1 | 2.93713604 |
| 15 | GRK5 | 2.89233742 |
| 16 | LMTK2 | 2.79940540 |
| 17 | PBK | 2.79021070 |
| 18 | MINK1 | 2.51544074 |
| 19 | MATK | 2.32369241 |
| 20 | MAP3K9 | 2.25156628 |
| 21 | BUB1 | 2.25015279 |
| 22 | RET | 2.14344833 |
| 23 | CDK19 | 2.09188718 |
| 24 | MARK3 | 2.02614134 |
| 25 | PAK6 | 1.91321814 |
| 26 | MAP2K2 | 1.82117997 |
| 27 | PLK4 | 1.78199460 |
| 28 | MAP3K1 | 1.69420717 |
| 29 | SIK2 | 1.60681247 |
| 30 | LATS2 | 1.55371851 |
| 31 | TESK2 | 1.52577205 |
| 32 | MAP2K1 | 1.49004158 |
| 33 | CDK4 | 1.47530475 |
| 34 | EPHA3 | 1.41544759 |
| 35 | GSK3A | 1.36138553 |
| 36 | ADRBK2 | 1.34560501 |
| 37 | STK39 | 1.34170408 |
| 38 | BRAF | 1.33251637 |
| 39 | AURKA | 1.32545854 |
| 40 | CDK6 | 1.26611129 |
| 41 | ADRBK1 | 1.24391047 |
| 42 | PHKG1 | 1.24326976 |
| 43 | PHKG2 | 1.24326976 |
| 44 | PAK4 | 1.21252548 |
| 45 | PIM1 | 1.21090388 |
| 46 | PLK1 | 1.21012277 |
| 47 | STK16 | 1.19437630 |
| 48 | CSK | 1.17534835 |
| 49 | ARAF | 1.15935861 |
| 50 | PINK1 | 1.14245830 |
| 51 | SGK223 | 1.13234251 |
| 52 | SGK494 | 1.13234251 |
| 53 | EPHB1 | 1.09352962 |
| 54 | SRPK1 | 1.07764918 |
| 55 | CASK | 1.06471604 |
| 56 | RPS6KA2 | 1.01812535 |
| 57 | IRAK2 | 1.01308856 |
| 58 | MARK2 | 0.98861808 |
| 59 | PRKCQ | 0.98205435 |
| 60 | CHEK1 | 0.97356068 |
| 61 | EIF2AK1 | 0.94866388 |
| 62 | WNK1 | 0.93693862 |
| 63 | TTK | 0.93654565 |
| 64 | MAP3K12 | 0.93158768 |
| 65 | MAP3K13 | 0.90871964 |
| 66 | PRKAA1 | 0.86166025 |
| 67 | UHMK1 | 0.85116678 |
| 68 | CSNK1G3 | 0.83634182 |
| 69 | CSNK1A1L | 0.82356736 |
| 70 | CDK5 | 0.81527448 |
| 71 | PRKCE | 0.78038278 |
| 72 | NEK1 | 0.75796900 |
| 73 | CSNK1G2 | 0.75229113 |
| 74 | BRD4 | 0.74808695 |
| 75 | EPHB2 | 0.74317061 |
| 76 | PLK2 | 0.73765969 |
| 77 | AKT2 | 0.73535438 |
| 78 | PAK1 | 0.70095255 |
| 79 | AURKB | 0.69011115 |
| 80 | WNK4 | 0.67349434 |
| 81 | CDK14 | 0.67323896 |
| 82 | PRKCD | 0.66816653 |
| 83 | LRRK2 | 0.66566530 |
| 84 | SIK1 | 0.65602448 |
| 85 | MAP3K4 | 0.65369814 |
| 86 | CHEK2 | 0.64679364 |
| 87 | PDPK1 | 0.64219395 |
| 88 | RPS6KB2 | 0.62718760 |
| 89 | FER | 0.62244065 |
| 90 | STK38L | 0.60695295 |
| 91 | PDK1 | 0.59983312 |
| 92 | TRPM7 | 0.58537659 |
| 93 | DYRK2 | 0.58198939 |
| 94 | LATS1 | 0.58069730 |
| 95 | FGR | 0.57382018 |
| 96 | CDC42BPA | 0.57071195 |
| 97 | ROCK2 | 0.57039932 |
| 98 | RAF1 | 0.56870307 |
| 99 | STK10 | 0.56709376 |
| 100 | PRKCG | 0.56410739 |
| 101 | MAP3K7 | 0.55784627 |
| 102 | KSR1 | 0.53870710 |
| 103 | FRK | 0.53801843 |
| 104 | CSNK1G1 | 0.53543718 |
| 105 | MARK1 | 0.53148911 |
| 106 | TESK1 | 0.52786213 |
| 107 | SCYL2 | 0.51725070 |
| 108 | MET | 0.50838751 |
| 109 | PKN1 | 0.50710237 |
| 110 | MELK | 0.50658895 |
| 111 | DAPK2 | 0.50504182 |
| 112 | PRKD3 | 0.49454603 |
| 113 | FES | 0.49069194 |
| 114 | STK4 | 0.48838365 |
| 115 | MAPK13 | 0.48651791 |
| 116 | EGFR | 0.48130876 |
| 117 | MST1R | 0.47766876 |
| 118 | PRKG2 | 0.47469693 |
| 119 | CAMK2A | 0.47403267 |
| 120 | PIM2 | 0.46703294 |
| 121 | YES1 | 0.46455700 |
| 122 | MAP2K4 | 0.44459106 |
| 123 | ABL1 | 0.43484016 |
| 124 | TNIK | 0.43172774 |
| 125 | NTRK2 | 0.43091957 |
| 126 | PRKAA2 | 0.42886018 |
| 127 | BCKDK | 0.42062317 |
| 128 | SRC | 0.40763575 |
| 129 | FGFR3 | 0.39702132 |
| 130 | TNK2 | 0.39530016 |
| 131 | MAPKAPK5 | 0.39139568 |
| 132 | FYN | 0.38659559 |
| 133 | CAMK2G | 0.38076406 |
| 134 | MST4 | 0.37697977 |
| 135 | JAK2 | 0.37324531 |
| 136 | SGK2 | 0.36907728 |
| 137 | ROCK1 | 0.36568384 |
| 138 | CAMK2D | 0.36427033 |
| 139 | PRKACA | 0.35754209 |
| 140 | PRKCI | 0.35271471 |
| 141 | CDK2 | 0.35112691 |
| 142 | CDK18 | 0.34032116 |
| 143 | PRKCH | 0.33927031 |
| 144 | HIPK2 | 0.33522456 |
| 145 | RPS6KA1 | 0.33443049 |
| 146 | PRKCZ | 0.33354119 |
| 147 | CAMKK1 | 0.32991842 |
| 148 | NEK6 | 0.32210352 |
| 149 | JAK3 | 0.31989125 |
| 150 | SGK3 | 0.30300875 |
| 151 | ABL2 | 0.30199003 |
| 152 | PRKCB | 0.30123864 |
| 153 | VRK2 | 0.30090906 |
| 154 | PTK2 | 0.29673233 |
| 155 | CSNK2A1 | 0.28116361 |
| 156 | CDK15 | 0.27073660 |
| 157 | PRKCA | 0.26623324 |
| 158 | MAP3K8 | 0.26465227 |
| 159 | FGFR4 | 0.26270721 |
| 160 | MAPK10 | 0.26179664 |
| 161 | ILK | 0.25883065 |
| 162 | CSNK2A2 | 0.25082000 |
| 163 | BRSK1 | 0.24534472 |
| 164 | RPS6KA4 | 0.23056543 |
| 165 | RPS6KB1 | 0.22857855 |
| 166 | CDK1 | 0.22236339 |
| 167 | MAPK1 | 0.22002713 |
| 168 | MTOR | 0.21489950 |
| 169 | ERBB4 | 0.20971499 |
| 170 | CDK7 | 0.19279074 |
| 171 | MAP3K6 | 0.19246794 |
| 172 | STK38 | 0.18223435 |
| 173 | DAPK1 | 0.16902406 |
| 174 | AKT1 | 0.16299960 |
| 175 | GRK6 | 0.16090398 |
| 176 | KDR | 0.15684693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.12262475 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.26985834 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 2.99956188 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.94438699 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.74153068 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.72521945 |
| 7 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.72434179 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.63405546 |
| 9 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.37461115 |
| 10 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.33824409 |
| 11 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.32200243 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.31981132 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.24380880 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 2.16188976 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.07721140 |
| 16 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.02650165 |
| 17 | Thyroid cancer_Homo sapiens_hsa05216 | 2.01349099 |
| 18 | p53 signaling pathway_Homo sapiens_hsa04115 | 2.01097698 |
| 19 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.95774691 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.91754389 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.89329841 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.78846621 |
| 23 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.76133087 |
| 24 | Base excision repair_Homo sapiens_hsa03410 | 1.76120919 |
| 25 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.73933069 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.70223495 |
| 27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.65271922 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.64966289 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.55603511 |
| 30 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.55546281 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.49847713 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.41785793 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.39812953 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.36188142 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.35785571 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.35647729 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.34424746 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34084059 |
| 39 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.33439404 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.33308736 |
| 41 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.32904846 |
| 42 | Long-term potentiation_Homo sapiens_hsa04720 | 1.31377306 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.30655388 |
| 44 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.30527877 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.29103624 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.26988341 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.26671949 |
| 48 | Parkinsons disease_Homo sapiens_hsa05012 | 1.25287659 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 1.23397013 |
| 50 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23067595 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.21891339 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.20925373 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.20340219 |
| 54 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.19797795 |
| 55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17687439 |
| 56 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.17264553 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17029630 |
| 58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.16673322 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.15551141 |
| 60 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.15120443 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 1.13309440 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 1.12712473 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.12447337 |
| 64 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.12005443 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 1.11883641 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 1.11734140 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.10096550 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08109133 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 1.07672377 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06338379 |
| 71 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06119749 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 1.03468868 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.01990161 |
| 74 | Spliceosome_Homo sapiens_hsa03040 | 1.00037338 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99331778 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.98695061 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98114781 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.98012145 |
| 79 | Long-term depression_Homo sapiens_hsa04730 | 0.96548080 |
| 80 | Melanoma_Homo sapiens_hsa05218 | 0.96366777 |
| 81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96205134 |
| 82 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.95738701 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.95597479 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93709810 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93493532 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.91916784 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91414404 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89697106 |
| 89 | Basal transcription factors_Homo sapiens_hsa03022 | 0.89642895 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87653185 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87394852 |
| 92 | Gap junction_Homo sapiens_hsa04540 | 0.87084087 |
| 93 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87054318 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83393504 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.83206286 |
| 96 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81075110 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80794012 |
| 98 | Melanogenesis_Homo sapiens_hsa04916 | 0.80511447 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.80265436 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79753483 |
| 101 | Nicotine addiction_Homo sapiens_hsa05033 | 0.79551546 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78193368 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76934061 |
| 104 | Purine metabolism_Homo sapiens_hsa00230 | 0.75888655 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75343126 |
| 106 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74706468 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.72563832 |
| 108 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72410914 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72388410 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71938152 |
| 111 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.71809242 |
| 112 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71743013 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70374899 |
| 114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69421210 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69302569 |
| 116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69061311 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.67616899 |
| 118 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66038094 |
| 119 | Homologous recombination_Homo sapiens_hsa03440 | 0.65231794 |
| 120 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.64918179 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64061936 |
| 122 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64040482 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.63021365 |
| 124 | Mismatch repair_Homo sapiens_hsa03430 | 0.61929124 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.61228837 |
| 126 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59191623 |
| 127 | Renin secretion_Homo sapiens_hsa04924 | 0.58948302 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58685170 |
| 129 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.58530031 |
| 130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57761496 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57473086 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56840588 |
| 133 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56770568 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56549194 |
| 135 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54571573 |
| 136 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54491559 |
| 137 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54359816 |
| 138 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53777897 |
| 139 | Protein export_Homo sapiens_hsa03060 | 0.53099335 |
| 140 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52225597 |
| 141 | Huntingtons disease_Homo sapiens_hsa05016 | 0.51605435 |
| 142 | Lysosome_Homo sapiens_hsa04142 | 0.51278327 |
| 143 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49213795 |
| 144 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48856957 |
| 145 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48141846 |
| 146 | Amoebiasis_Homo sapiens_hsa05146 | 0.47827788 |
| 147 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47392016 |
| 148 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47347310 |
| 149 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47143838 |
| 150 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46449988 |
| 151 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45266575 |
| 152 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43534310 |
| 153 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.42987697 |
| 154 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41745467 |
| 155 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41522163 |
| 156 | Phototransduction_Homo sapiens_hsa04744 | 0.41484006 |
| 157 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40004549 |
| 158 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.39555188 |
| 159 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.39320348 |
| 160 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.38409093 |
| 161 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.36688755 |
| 162 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35729439 |
| 163 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34192228 |
| 164 | Measles_Homo sapiens_hsa05162 | 0.33146835 |
| 165 | Prostate cancer_Homo sapiens_hsa05215 | 0.32813028 |
| 166 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.32012871 |
| 167 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31992233 |
| 168 | ABC transporters_Homo sapiens_hsa02010 | 0.30803445 |
| 169 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.29461781 |
| 170 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29140686 |
| 171 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28870174 |
| 172 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.27447347 |
| 173 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.21318783 |

